Skip to content

Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis

Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00835874
Enrollment
57
Registered
2009-02-04
Start date
2007-06-30
Completion date
2009-07-31
Last updated
2012-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Necrotizing Enterocolitis, Sepsis

Keywords

probiotic, preterm, lactation, breast feeding, necrotizing enterocolitis, sepsis, bacterial cultures, lactating mother, breast feeding of at least 50% of enteric feeding volume, Infant, very low birth weight

Brief summary

We hypothesize that supplementing maternal diet with probiotics will decrease the incidence of feeding intolerance, necrotizing enterocolitis and sepsis in preterm infants fed breastmilk.

Detailed description

Oral probiotics have previously been shown to prevent necrotizing enterocolitis in preterm infants. A few reports of sepsis by a probiotic bacteria have impeded implementation of oral probiotic supplementation in most NICUs. Considering the proven immunomodulatory effect of maternal probiotics on breastfed infants of atopic mothers, we would like to explore the indirect effects of maternal probiotics on preterm infants

Interventions

DRUGProbiotics

Lactobacillus acidophilus, b.lactis capsule. Once daily.2X 10 by the power of 10 bacteria per dose.

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Mothers of preterm infants * Pumping breast milk

Exclusion criteria

* Neonatal congenital anomalies

Design outcomes

Primary

MeasureTime frame
all cause mortality at three months of age3 months
incidence and severity of necrotizing enterocolitis by Bell's staging at Three months3 months
occurrence of bacterial or fungal infection per blood,csf or urine cultures at three months3 months

Secondary

MeasureTime frame
incidence of BPD, PVL, ROP36 weeks
maternal adverse effects during treatment3 months

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026